The anti-diabetes drug metformin is showing some successes in treating breast cancer including Herceptin-resistant breast cancers [313-317] A target of metformin is AMPK which is involved in regulation of components of the PI3K/Akt/mTORC1 and GSK-3 pathways. The gene discussed is PIK3CA; the disease is breast cancer.